morphine sulfate


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.

mor·phine sul·fate (MS),

morphine used for formulation of tablets as well as solutions for parenteral, epidural, or intrathecal injection to relieve pain.

morphine sulfate

an opioid analgesic.
indications It is prescribed for relief of moderate to severe pain, including that from myocardial infarction and dyspnea caused by left heart failure, and as a preanesthetic.
contraindications Drug dependence or known hypersensitivity to this drug prohibits its use.
adverse effects Among the more serious adverse effects are increased intracranial pressure, cardiovascular disturbances, respiratory depression, and drug dependence. Nausea, vomiting, constipation, and xerostomia are common.

mor·phine sul·fate

(mōr'fēn sŭl'fāt)
Agent used for formulation of tablets as well as solutions for parenteral, epidural, or intrathecal injection to relieve pain.

mor·phine sul·fate

(MS) (mōr'fēn sŭl'fāt)
Morphine used for parenteral, epidural, or intrathecal injection to relieve pain.

morphine sulfate,

n brand names: Duramorph PF, MS Contin, Roxanol;
drug class: narcotic analgesic (Controlled Substance Schedule II);
action: depresses pain impulse transmission at the central nervous system by interacting with opioid receptors;
use: severe pain.
References in periodicals archive ?
No adducted nucleotides could be detected on chromatograms prepared from cells treated either saline or mitomycin C followed by incubated with either saline of morphine sulfate for an additional 2 h.
Morphine sulfate does not persist in tissues, and 24 hours after a dose, concentration is low.
Respiratory depression is the primary risk of morphine sulfate.
Comprehensive Table of Contents and more for the report "Global and Chinese Morphine Sulfate (CAS 64-31-3) Industry, 2009-2019 Market Research Report" is available at http://www.
The FDA is willing to fast-track an approval application from any company for the concentrated morphine sulfate elixir, Dr.
Respiratory Depression Respiratory depression is the primary risk of Morphine Sulfate Injection USP.
Upsher-Smith's family of Morphine Sulfate Extended-Release Capsules, CII includes seven dosage strengths: 10 mg, 20 mg, 30 mg, 50 mg, 60 mg, 80 mg, and 100 mg.
Take care when prescribing and administering morphine sulfate oral solution to avoid dosing errors due to confusion between different concentrations and between mg and mL, which could result in accidental overdose and death.
Vasopressin 20 Units/1 Ml In 1ml Multi Dose Vial Morphine Sulfate 10 Mg Ampoule/vial Zemurom Lomg Vial Ndc# 0052-0450-10
Food and Drug Administration for its abbreviated new drug application for morphine sulfate 100ml/5% oral solution.
Food and Drug Administration (FDA) has issued a revised Prescription Drug User Fee Act (PDUFA) goal date of June 23, 2011 for the company's 505(b)(2) New Drug Application for Morphine Sulfate Oral Solution.
Tenders are invited for Supply of Medicines, Morphine Sulfate Injection, Naloxone Injection, Diazepam, Fluid Giving Sets, Suture Nylon, Sachets Skin Disinfectant, Infusion Bottle Holder, Nelaton Catheter.